About LabEx IGO

The LabEx IGO "Immunotherapy-Graft-Oncology" aims at fostering transdisciplinary projects between 20 scientific teams in Nantes, Angers, Rennes and Brest, with complementary expertise in transplantation and tumor immunology, autoimmunity, inflammation, radio-immunotherapy, infection & host/pathogen interactions.


It was labeled in 2012 by the French Ministry of Research and Education among very competitive scientific clusters of excellence called LabEx for “Laboratoire d’Excellence”, as part of the governmental initiative “Investissements d’Avenir” (investing in the future). These initiatives aim to distribute significant resources to French laboratories to increase their international visibility and attractivity, to develop research, to support training initiatives and to promote research findings.

The LabEx IGO was initially endowed with 5,5 M € for a 8-year period, from March 2012 to December 2019. In 2019, following an evaluation by an international jury, based on its scientific results and the impact of its activities on the structuring of immunology teams in the French large-western region, the LabEx IGO was extended for 5 years (2020-2024) with a new allocation of 2,2 M €.

Currently, the LabEx IGO gathers about 570 people (scientists, students, technical staff) from 20 research teams located in 5 academic research units (UMR1307, UMR1064, UMR1236, UMR1227, UMR1302) of the French large-western region (Nantes, Angers, Rennes, Brest).

Follow us on

Mis à jour le 01 July 2022.